WO1998020165A3 - Biallelic markers - Google Patents

Biallelic markers Download PDF

Info

Publication number
WO1998020165A3
WO1998020165A3 PCT/US1997/020313 US9720313W WO9820165A3 WO 1998020165 A3 WO1998020165 A3 WO 1998020165A3 US 9720313 W US9720313 W US 9720313W WO 9820165 A3 WO9820165 A3 WO 9820165A3
Authority
WO
WIPO (PCT)
Prior art keywords
biallelic markers
probes
sites
primers
forensics
Prior art date
Application number
PCT/US1997/020313
Other languages
French (fr)
Other versions
WO1998020165A2 (en
Inventor
Eric S Lander
David Wang
Thomas Hudson
Original Assignee
Whitehead Biomedical Inst
Eric S Lander
David Wang
Thomas Hudson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst, Eric S Lander, David Wang, Thomas Hudson filed Critical Whitehead Biomedical Inst
Priority to EP97946582A priority Critical patent/EP0941366A2/en
Publication of WO1998020165A2 publication Critical patent/WO1998020165A2/en
Publication of WO1998020165A3 publication Critical patent/WO1998020165A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides nucleic acid segments of the human genome including polymorphic sites. Allele-specific primers and probes hybridizing to regions flanking these sites are also provided. The nucleic acids, primers and probes are used in applications such as forensics, paternity testing, medicine and genetic analysis.
PCT/US1997/020313 1996-11-06 1997-11-05 Biallelic markers WO1998020165A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP97946582A EP0941366A2 (en) 1996-11-06 1997-11-05 Biallelic markers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3045596P 1996-11-06 1996-11-06
US60/030,455 1996-11-06

Publications (2)

Publication Number Publication Date
WO1998020165A2 WO1998020165A2 (en) 1998-05-14
WO1998020165A3 true WO1998020165A3 (en) 1998-11-12

Family

ID=21854280

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/020313 WO1998020165A2 (en) 1996-11-06 1997-11-05 Biallelic markers

Country Status (2)

Country Link
EP (1) EP0941366A2 (en)
WO (1) WO1998020165A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9102707B2 (en) 2011-08-30 2015-08-11 Mayo Foundation For Medical Education And Research Natriuretic polypeptides

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391550B1 (en) 1996-09-19 2002-05-21 Affymetrix, Inc. Identification of molecular sequence signatures and methods involving the same
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6277977B1 (en) * 1997-06-11 2001-08-21 Smithkline Beecham Corporation cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor
US7105353B2 (en) 1997-07-18 2006-09-12 Serono Genetics Institute S.A. Methods of identifying individuals for inclusion in drug studies
FR2767135B1 (en) 1997-08-06 2002-07-12 Genset Sa LSR COMPLEX RECEPTOR, ACTIVITY, CLONING, AND APPLICATION TO DIAGNOSIS, PREVENTION AND / OR TREATMENT OF OBESITY AND THE RISKS OR COMPLICATIONS THEREOF
US6482923B1 (en) 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
US6849719B2 (en) 1997-09-17 2005-02-01 Human Genome Sciences, Inc. Antibody to an IL-17 receptor like protein
EP1015488B1 (en) 1997-09-17 2009-09-09 Human Genome Sciences, Inc. Interleukin-17 receptor-like protein
CA2584482C (en) 1998-02-05 2012-03-27 Smithkline Beecham Biologicals S.A. Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
JP2002502600A (en) 1998-02-06 2002-01-29 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Human serine protease and serpin polypeptide
US6692909B1 (en) * 1998-04-01 2004-02-17 Whitehead Institute For Biomedical Research Coding sequence polymorphisms in vascular pathology genes
EP1068354A2 (en) * 1998-04-09 2001-01-17 Whitehead Institute For Biomedical Research Biallelic markers
US6537751B1 (en) 1998-04-21 2003-03-25 Genset S.A. Biallelic markers for use in constructing a high density disequilibrium map of the human genome
EP1071817A2 (en) * 1998-04-21 2001-01-31 Genset Biallelic markers for use in constructing a high density disequilibrium map of the human genome
US20030032061A1 (en) 1998-05-15 2003-02-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6251592B1 (en) * 1998-05-26 2001-06-26 Procrea Biosciences Inc. STR marker system for DNA fingerprinting
US6759192B1 (en) 1998-06-05 2004-07-06 Genset S.A. Polymorphic markers of prostate carcinoma tumor antigen-1(PCTA-1)
ATE409226T1 (en) * 1998-06-05 2008-10-15 Serono Genetics Inst Sa POLYMORPHOIC MARKERS OF PROSTATE CARCINOMA TUMOR ANTIGEN-1 (PCTA-1)
US6825004B1 (en) 1998-08-07 2004-11-30 Genset S.A. Nucleic acids encoding human TBC-1 protein and polymorphic markers thereof
JP2002532057A (en) * 1998-08-07 2002-10-02 ジェンセット Nucleic acid encoding human TBC-1 protein and polymorphic marker thereof
JP2002525127A (en) * 1998-09-25 2002-08-13 マサチューセッツ インスティテュート オブ テクノロジー Methods and products for genotyping and DNA analysis
US6703228B1 (en) 1998-09-25 2004-03-09 Massachusetts Institute Of Technology Methods and products related to genotyping and DNA analysis
US7067627B2 (en) 1999-03-30 2006-06-27 Serono Genetics Institute S.A. Schizophrenia associated genes, proteins and biallelic markers
US6476208B1 (en) 1998-10-13 2002-11-05 Genset Schizophrenia associated genes, proteins and biallelic markers
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6361947B1 (en) 1998-10-27 2002-03-26 Affymetrix, Inc. Complexity management and analysis of genomic DNA
EP1127120B1 (en) 1998-11-04 2008-05-28 Serono Genetics Institute S.A. Genomic and complete cdna sequences of human adipocyte-specific apm1 and biallelic markers thereof
US6291182B1 (en) * 1998-11-10 2001-09-18 Genset Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait
US6670464B1 (en) * 1998-11-17 2003-12-30 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP1141384A2 (en) 1999-01-06 2001-10-10 Cornell Research Foundation, Inc. Method for accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing
US8367322B2 (en) 1999-01-06 2013-02-05 Cornell Research Foundation, Inc. Accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing
WO2000042165A2 (en) * 1999-01-15 2000-07-20 Human Genome Sciences, Inc. Bone marrow-specific protein
ES2323445T3 (en) 1999-02-10 2009-07-16 Serono Genetics Institute S.A. GEN LSR POLYMORPHIC MARKERS.
US8133734B2 (en) 1999-03-16 2012-03-13 Human Genome Sciences, Inc. Kit comprising an antibody to interleukin 17 receptor-like protein
AU3899700A (en) * 1999-03-17 2000-10-04 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
EP1165835A2 (en) 1999-03-24 2002-01-02 Serono Genetics Institute S.A. GENOMIC SEQUENCE OF THE $i(PURH) GENE AND $i(PURH)-RELATED BIALLELIC MARKERS
WO2000058510A2 (en) * 1999-03-30 2000-10-05 Genset Schizophrenia associated genes, proteins and biallelic markers
WO2000058519A2 (en) * 1999-03-31 2000-10-05 Whitehead Institute For Biomedical Research Charaterization of single nucleotide polymorphisms in coding regions of human genes
IL129734A0 (en) * 1999-05-03 2000-02-29 Compugen Ltd Novel nucleic acid and amino acid sequences
JP2003518918A (en) * 1999-05-25 2003-06-17 アバンテイス・フアルマ・エス・アー Expression products of genes involved in cholesterol metabolism disorders
FR2794131B1 (en) * 1999-05-25 2003-12-12 Aventis Pharma Sa GENE EXPRESSION PRODUCTS INVOLVED IN CONDITIONS ASSOCIATED WITH THE METABOLISM OF CHOLESTEROL
AU781437B2 (en) * 1999-06-25 2005-05-26 Serono Genetics Institute S.A. A novel BAP28 gene and protein
EP1088900A1 (en) * 1999-09-10 2001-04-04 Epidauros Biotechnologie AG Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications
US6555316B1 (en) 1999-10-12 2003-04-29 Genset S.A. Schizophrenia associated gene, proteins and biallelic markers
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
AU1928801A (en) * 1999-11-24 2001-06-04 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
US6869762B1 (en) 1999-12-10 2005-03-22 Whitehead Institute For Biomedical Research Crohn's disease-related polymorphisms
CA2394033A1 (en) * 1999-12-10 2001-06-14 Whitehead Institute For Biomedical Research Ibd-related polymorphisms
CA2395779A1 (en) * 1999-12-27 2001-07-05 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001048245A2 (en) * 1999-12-27 2001-07-05 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001047944A2 (en) * 1999-12-28 2001-07-05 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
WO2001051670A2 (en) * 2000-01-07 2001-07-19 Curagen Corporation Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
US7338787B2 (en) 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
US6566332B2 (en) 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US20020058617A1 (en) 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
US6989367B2 (en) 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
US20020032319A1 (en) * 2000-03-07 2002-03-14 Whitehead Institute For Biomedical Research Human single nucleotide polymorphisms
WO2001079504A1 (en) * 2000-04-13 2001-10-25 Millennium Pharmaceuticals, Inc. 23155 NOVEL PROTEIN HUMAN 5-α REDUCTASES AND USES THEREFOR
GB0016169D0 (en) * 2000-06-30 2000-08-23 Univ London Diagnostic method
CA2436516A1 (en) * 2001-02-20 2002-08-29 Caroline Barry Pg-3 and biallelic markers thereof
FR2824333B1 (en) * 2001-05-03 2003-08-08 Genodyssee NOVEL POLYNUCLEOTIDES AND POLYPEPTIDES OF IFN ALPHA 5
DE10122847A1 (en) * 2001-05-11 2002-11-21 Noxxon Pharma Ag New nucleic acid that binds to staphylococcal enterotoxin B, useful for treating and diagnosing e.g. septic shock, identified by the SELEX method
JP4336877B2 (en) * 2003-04-18 2009-09-30 アークレイ株式会社 Method for detecting β3 adrenergic receptor mutant gene and nucleic acid probe and kit therefor
EP1913155A4 (en) * 2005-06-23 2009-08-12 Univ British Columbia Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy
WO2007035600A2 (en) * 2005-09-16 2007-03-29 Mayo Foundation For Education And Research Natriuretic activities
US9388457B2 (en) 2007-09-14 2016-07-12 Affymetrix, Inc. Locus specific amplification using array probes
US9074244B2 (en) 2008-03-11 2015-07-07 Affymetrix, Inc. Array-based translocation and rearrangement assays
WO2009143576A1 (en) * 2008-05-27 2009-12-03 Adelaide Research & Innovation Pty Ltd Polymorphisms associated with pregnancy complications
US20120108514A1 (en) 2009-07-09 2012-05-03 University Of Iowa Research Foundation Long acting atrial natriuretic peptide (la-anp) and methods for use thereof
WO2011151405A1 (en) 2010-06-04 2011-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence
US9611305B2 (en) 2012-01-06 2017-04-04 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
CN111139301B (en) * 2020-03-10 2020-12-18 无锡市第五人民医院 Breast cancer related gene ERBB2 site g.39397319C > A mutant and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012607A1 (en) * 1993-11-03 1995-05-11 Molecular Tool, Inc. Single nucleotide polymorphisms and their use in genetic analysis
FR2722295A1 (en) * 1994-07-07 1996-01-12 Roussy Inst Gustave Single strand conformation polymorphism analysis of DNA

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012607A1 (en) * 1993-11-03 1995-05-11 Molecular Tool, Inc. Single nucleotide polymorphisms and their use in genetic analysis
FR2722295A1 (en) * 1994-07-07 1996-01-12 Roussy Inst Gustave Single strand conformation polymorphism analysis of DNA

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE EMEST10 embl; 12 January 1995 (1995-01-12), ADAMS M D ET AL.: "Initial assessment of human gene diversity and expression patterns based upon 52 million basepairs of cDNA sequence", XP002067789 *
GROMPE M: "THE RAPID DETECTION OF UNKNOWN MUTATIONS IN NUCLEIC ACIDS", NATURE GENETICS, vol. 5, no. 2, October 1993 (1993-10-01), pages 111 - 117, XP000615290 *
HRUBAN R H ET AL: "K-RAS ONCOGENE ACTIVATION IN ADENOCARCINOMA OF THE HUMAN PANCREAS A STUDY OF 82 CARCINOMAS USING A COMBINATION OF MUTANT-ENRICHED POLYMERASE CHAIN RACTION ANALYSIS AND ALLELE-SPECIFIC OLIGONUCLEOTIDE HYBRIDIZATION", AMERICAN JOURNAL OF PATHOLOGY, vol. 143, no. 2, 1 August 1993 (1993-08-01), pages 545 - 554, XP000572114 *
NIKIFOROV T T ET AL: "GENETIC BIT ANALYSIS: A SOLID PHASE METHOD FOR TYPING SINGLE NUCLEOTIDE POLYMORPHISMS", NUCLEIC ACIDS RESEARCH, vol. 22, no. 20, October 1994 (1994-10-01), pages 4167 - 4175, XP002015765 *
SYVANEN A -CH ET AL: "IDENTIFICATION OF INDIVIDUALS BY ANALYSIS OF BIALLELIC DNA MARKERS,USING PCR AND SOLID-PHASE MINISEQUENCING", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 52, no. 1, January 1993 (1993-01-01), pages 46 - 59, XP002050638 *
WANG D ET AL: "TOWARD A THIRD GENERATION GENETIC MAP OF THE HUMAN GENOME BASED ON BI-ALLELIC POLYMORPHISMS", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 59, no. 4, October 1996 (1996-10-01), pages A03, XP002050641 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9102707B2 (en) 2011-08-30 2015-08-11 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
US9441027B2 (en) 2011-08-30 2016-09-13 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
US9587004B2 (en) 2011-08-30 2017-03-07 Mayo Foundation For Medical Education And Research Natriuretic polypeptides

Also Published As

Publication number Publication date
WO1998020165A2 (en) 1998-05-14
EP0941366A2 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
WO1998020165A3 (en) Biallelic markers
CA2172722A1 (en) Methods and compositions for efficient nucleic acid sequencing
CA2289872A1 (en) Target-dependent reactions using structure-bridging oligonucleotides
CA2294516A1 (en) Ikk-.beta. proteins, nucleic acids and methods
CA2295999A1 (en) Nik proteins, nucleic acids and methods
WO2001042508A3 (en) Methods and compositions relating to electrical detection of nucleic acid reactions
WO2001066800A3 (en) Human single nucleotide polymorphisms
EP0995804A3 (en) Nucleic acid analysis using complete N-mer arrays
CA2281895A1 (en) Ikb kinases
ATE245190T1 (en) ROBO: A FAMILY OF POLYPEPTIDES AND NUCLEIC ACIDS EFFECTIVE IN NERVE CELL CONDUCTION
CA2294566A1 (en) Ikk-.alpha. proteins, nucleic acids and methods
WO1999050454A3 (en) Coding sequence polymorphisms in vascular pathology genes
EP1757616A3 (en) Semaphorin receptors
WO1999053095A3 (en) Biallelic markers
WO2001042511A3 (en) Ibd-related polymorphisms
WO2000058519A3 (en) Charaterization of single nucleotide polymorphisms in coding regions of human genes
WO2001018250A3 (en) Single nucleotide polymorphisms in genes
WO2001038576A3 (en) Human single nucleotide polymorphisms
WO2003054167A3 (en) Identification of novel polymorphic sites in the human mglur8 gene and uses thereof
CA2348828A1 (en) Genomic and complete cdna sequences of apm1 and biallelic markers thereof
ATE211180T1 (en) METHOD FOR THE NON-RADIOACTIVE DETECTION OF MEMBRANE-BONDED NUCLEIC ACIDS AND TEST KIT
WO2000034476A3 (en) Nucleic acid molecules of shrimp
WO2001066801A3 (en) Very low density lipoprotein receptor polymorphisms and uses therefor
WO2001034840A3 (en) Genetic compositions and methods
ATE196778T1 (en) ELEVEN HIGHLY INFORMATIVE POLYMORPH REPEATED MICROSATELLITE DNA MARKERS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1997946582

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997946582

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997946582

Country of ref document: EP